Wedbush Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: Wedbush
Rating: 2.7
Author: MarketBeat

→ Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad)

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Wedbush. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Wedbush.

Company	Current Price	Rating Date	Action	Brokerage	Analyst	Rating	Price Target	Impact on Price	Details
DENN Denny's	$8.07 -2.2%	4/26/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$10.50 -> $9.50	Low	View details for Wedbush rating of Denny’s (NASDAQ:DENN) on 4/26/2024
DPZ Domino's Pizza	$499.07 +0.9%	4/26/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$520.00	Low	View details for Wedbush rating of Domino’s Pizza (NYSE:DPZ) on 4/26/2024
EAT Brinker International	$48.83 +1.2%	4/26/2024	Target Raised by	Wedbush	-	Neutral -> Neutral	$45.00 -> $47.00	Low	View details for Wedbush rating of Brinker International (NYSE:EAT) on 4/26/2024
MCD McDonald's	$273.09 -0.9%	4/26/2024	Target Lowered by	Wedbush	-	Outperform -> Outperform	$330.00 -> $300.00	Low	View details for Wedbush rating of McDonald’s (NYSE:MCD) on 4/26/2024
SBUX Starbucks	$88.25 +0.5%	4/26/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$95.00 -> $92.00	Low	View details for Wedbush rating of Starbucks (NASDAQ:SBUX) on 4/26/2024
WEN Wendy's	$20.14 +1.6%	4/26/2024	Target Raised by	Wedbush	Analyst N. Setyan	Neutral -> Neutral	$19.00 -> $20.00	Low	View details for Wedbush rating of Wendy’s (NASDAQ:WEN) on 4/26/2024
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
WING Wingstop	$382.56 +3.4%	4/26/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$340.00 -> $400.00	Low	View details for Wedbush rating of Wingstop (NASDAQ:WING) on 4/26/2024
CHKP Check Point Software Technologies	$151.20 -1.1%	4/26/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$185.00	Low	View details for Wedbush rating of Check Point Software Technologies (NASDAQ:CHKP) on 4/26/2024
ROKU Roku	$56.35 -10.3%	4/26/2024	Target Lowered by	Wedbush	-	Outperform -> Outperform	$80.00 -> $75.00	Low	View details for Wedbush rating of Roku (NASDAQ:ROKU) on 4/26/2024
INTC Intel	$31.88 -9.2%	4/26/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$40.00 -> $32.50	Low	View details for Wedbush rating of Intel (NASDAQ:INTC) on 4/26/2024
IMAX IMAX	$17.15 -1.8%	4/26/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$22.00	Low	View details for Wedbush rating of IMAX (NYSE:IMAX) on 4/26/2024
BPMC Blueprint Medicines	$93.00 +2.5%	4/26/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$110.00	Low	View details for Wedbush rating of Blueprint Medicines (NASDAQ:BPMC) on 4/26/2024
SKX Skechers U.S.A.	$65.41 +11.2%	4/26/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$68.00 -> $76.00	Low	View details for Wedbush rating of Skechers U.S.A. (NYSE:SKX) on 4/26/2024
WDC Western Digital	$71.36 +2.8%	4/26/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$85.00	Low	View details for Wedbush rating of Western Digital (NASDAQ:WDC) on 4/26/2024
PEGA Pegasystems	$61.80 +4.6%	4/26/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$90.00	Low	View details for Wedbush rating of Pegasystems (NASDAQ:PEGA) on 4/26/2024
CFR Cullen/Frost Bankers	$107.08 -3.3%	4/26/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$115.00	Low	View details for Wedbush rating of Cullen/Frost Bankers (NYSE:CFR) on 4/26/2024
CUBI Customers Bancorp	$46.82 -5.5%	4/26/2024	Target Lowered by	Wedbush	-	Outperform -> Outperform	$63.00 -> $61.00	Low	View details for Wedbush rating of Customers Bancorp (NYSE:CUBI) on 4/26/2024
VLY Valley National Bancorp	$7.32 -5.8%	4/26/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$9.00 -> $8.00	Low	View details for Wedbush rating of Valley National Bancorp (NASDAQ:VLY) on 4/26/2024
FFWM First Foundation	$6.08 -9.3%	4/26/2024	Target Lowered by	Wedbush	Analyst D. Chiaverini	Neutral -> Neutral	$8.00 -> $7.00	Low	View details for Wedbush rating of First Foundation (NASDAQ:FFWM) on 4/26/2024
COLB Columbia Banking System	$19.12 +0.6%	4/26/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$20.00	Low	View details for Wedbush rating of Columbia Banking System (NASDAQ:COLB) on 4/26/2024
GOOGL Alphabet	$171.95 +10.2%	4/26/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$175.00 -> $205.00	Low	View details for Wedbush rating of Alphabet (NASDAQ:GOOGL) on 4/26/2024
MSFT Microsoft	$406.32 +1.8%	4/26/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$500.00	Low	View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 4/26/2024
SNBR Sleep Number	$14.18 -0.4%	4/25/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$13.50	Low	View details for Wedbush rating of Sleep Number (NASDAQ:SNBR) on 4/25/2024
DBD Diebold Nixdorf	$32.03 -0.9%	4/25/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$40.00	Low	View details for Wedbush rating of Diebold Nixdorf (NYSE:DBD) on 4/25/2024
ALIT Alight	$9.11	4/25/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$14.00	Low	View details for Wedbush rating of Alight (NYSE:ALIT) on 4/25/2024
FUBO fuboTV	$1.39 +1.5%	4/25/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$5.00	Low	View details for Wedbush rating of fuboTV (NYSE:FUBO) on 4/25/2024
CNK Cinemark	$17.65 +1.0%	4/25/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$23.00	Low	View details for Wedbush rating of Cinemark (NYSE:CNK) on 4/25/2024
SLM SLM	$21.90 -0.1%	4/25/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$26.00 -> $28.00	Low	View details for Wedbush rating of SLM (NASDAQ:SLM) on 4/25/2024
PPBI Pacific Premier Bancorp	$21.98 -0.8%	4/25/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$25.00	Low	View details for Wedbush rating of Pacific Premier Bancorp (NASDAQ:PPBI) on 4/25/2024
COOP Mr. Cooper Group	$78.73 0.0%	4/25/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$85.00 -> $100.00	Low	View details for Wedbush rating of Mr. Cooper Group (NASDAQ:COOP) on 4/25/2024
PFSI PennyMac Financial Services	$87.00 +0.9%	4/25/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$110.00	Low	View details for Wedbush rating of PennyMac Financial Services (NYSE:PFSI) on 4/25/2024
BIIB Biogen	$208.90 +3.2%	4/25/2024	Target Raised by	Wedbush	-	Neutral -> Neutral	$213.00 -> $215.00	Low	View details for Wedbush rating of Biogen (NASDAQ:BIIB) on 4/25/2024
CCS Century Communities	$78.82 +0.6%	4/25/2024	Reiterated by	Wedbush	Analyst J. Mccanless	Underperform -> Underperform	$82.00	Low	View details for Wedbush rating of Century Communities (NYSE:CCS) on 4/25/2024
IBM International Business Machines	$167.13 -1.1%	4/25/2024	Target Raised by	Wedbush	-	Neutral -> Neutral	$140.00 -> $160.00	Low	View details for Wedbush rating of International Business Machines (NYSE:IBM) on 4/25/2024
CVBF CVB Financial	$16.48 -0.2%	4/25/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$19.00	Low	View details for Wedbush rating of CVB Financial (NASDAQ:CVBF) on 4/25/2024
MTH Meritage Homes	$169.48 +2.7%	4/25/2024	Reiterated by	Wedbush	Analyst J. Mccanless	Underperform -> Underperform	$148.00	Low	View details for Wedbush rating of Meritage Homes (NYSE:MTH) on 4/25/2024
TPH Tri Pointe Homes	$37.88 +2.9%	4/25/2024	Reiterated by	Wedbush	Analyst J. Mccanless	Neutral -> Neutral	$35.00	Low	View details for Wedbush rating of Tri Pointe Homes (NYSE:TPH) on 4/25/2024
ORLY O'Reilly Automotive	$1,043.93 -1.0%	4/25/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$1,100.00	Low	View details for Wedbush rating of O’Reilly Automotive (NASDAQ:ORLY) on 4/25/2024
CVNA Carvana	$84.31 +8.8%	4/25/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$60.00 -> $80.00	Low	View details for Wedbush rating of Carvana (NYSE:CVNA) on 4/25/2024
META Meta Platforms	$443.29 +0.4%	4/25/2024	Target Lowered by	Wedbush	-	Outperform -> Outperform	$570.00 -> $480.00	N/A	View details for Wedbush rating of Meta Platforms (NASDAQ:META) on 4/25/2024
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>>
CMG Chipotle Mexican Grill	$3,186.97 +2.4%	4/25/2024	Target Raised by	Wedbush	Analyst N. Setyan	Neutral -> Neutral	$2,850.00 -> $3,200.00	Low	View details for Wedbush rating of Chipotle Mexican Grill (NYSE:CMG) on 4/25/2024
FR First Industrial Realty Trust	$46.00 -0.1%	4/25/2024	Downgraded by	Wedbush	Analyst R. Anderson	Outperform -> Neutral	$59.00 -> $49.00	Low	View details for Wedbush rating of First Industrial Realty Trust (NYSE:FR) on 4/25/2024
MHO M/I Homes	$120.07 -0.2%	4/24/2024	Reiterated by	Wedbush	Analyst J. Mccanless	Neutral	$116.00 -> $130.00	Low	View details for Wedbush rating of M/I Homes (NYSE:MHO) on 4/24/2024
DAWN Day One Biopharmaceuticals	$14.92 +12.9%	4/24/2024	Reiterated by	Wedbush	-	Outperform	$33.00	Low	View details for Wedbush rating of Day One Biopharmaceuticals (NASDAQ:DAWN) on 4/24/2024
STX Seagate Technology	$86.04 -1.4%	4/24/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$100.00	Low	View details for Wedbush rating of Seagate Technology (NASDAQ:STX) on 4/24/2024
GM General Motors	$45.84 +0.5%	4/24/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$45.00 -> $55.00	Low	View details for Wedbush rating of General Motors (NYSE:GM) on 4/24/2024
V Visa	$274.52 -0.2%	4/24/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$280.00 -> $300.00	Low	View details for Wedbush rating of Visa (NYSE:V) on 4/24/2024
ETSY Etsy	$67.43 +0.3%	4/24/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$80.00 -> $70.00	Low	View details for Wedbush rating of Etsy (NASDAQ:ETSY) on 4/24/2024
EWBC East West Bancorp	$75.98 -0.5%	4/24/2024	Reiterated by	Wedbush	Analyst D. Chiaverini	Outperform -> Outperform	$90.00	Low	View details for Wedbush rating of East West Bancorp (NASDAQ:EWBC) on 4/24/2024
MELI MercadoLibre	$1,406.00 +3.1%	4/24/2024	Target Lowered by	Wedbush	-	Outperform -> Outperform	$2,000.00 -> $1,800.00	Low	View details for Wedbush rating of MercadoLibre (NASDAQ:MELI) on 4/24/2024
AMZN Amazon.com	$179.62 +3.4%	4/24/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$220.00 -> $225.00	Low	View details for Wedbush rating of Amazon.com (NASDAQ:AMZN) on 4/24/2024
BANC Banc of California	$14.32 +1.6%	4/24/2024	Target Lowered by	Wedbush	Analyst D. Chiaverini	Neutral -> Neutral	$16.00 -> $15.00	Low	View details for Wedbush rating of Banc of California (NYSE:BANC) on 4/24/2024
HAFC Hanmi Financial	$15.82 +1.2%	4/24/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$17.00	Low	View details for Wedbush rating of Hanmi Financial (NASDAQ:HAFC) on 4/24/2024
ARE Alexandria Real Estate Equities	$116.24 -0.9%	4/24/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$140.00	Low	View details for Wedbush rating of Alexandria Real Estate Equities (NYSE:ARE) on 4/24/2024
SMCI Super Micro Computer	$857.44 +8.9%	4/24/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$530.00	Low	View details for Wedbush rating of Super Micro Computer (NASDAQ:SMCI) on 4/24/2024
KNSA Kiniksa Pharmaceuticals	$17.88 +1.5%	4/23/2024	Reiterated by	Wedbush	-	Outperform	$30.00	Low	View details for Wedbush rating of Kiniksa Pharmaceuticals (NASDAQ:KNSA) on 4/23/2024
NTLA Intellia Therapeutics	$20.76 +3.7%	4/23/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$29.00	Low	View details for Wedbush rating of Intellia Therapeutics (NASDAQ:NTLA) on 4/23/2024
FATE Fate Therapeutics	$3.80 -1.8%	4/23/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$7.00	Low	View details for Wedbush rating of Fate Therapeutics (NASDAQ:FATE) on 4/23/2024
PRME Prime Medicine	$4.43 +3.0%	4/23/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$12.00	Low	View details for Wedbush rating of Prime Medicine (NYSE:PRME) on 4/23/2024
TCRX TScan Therapeutics	$7.32 +0.4%	4/23/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$10.00	Low	View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 4/23/2024
VOR Vor Biopharma	$1.69 -0.6%	4/23/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$11.00	Low	View details for Wedbush rating of Vor Biopharma (NYSE:VOR) on 4/23/2024
ACET Adicet Bio	$1.68 -7.2%	4/23/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$5.00	Low	View details for Wedbush rating of Adicet Bio (NASDAQ:ACET) on 4/23/2024
BEAM Beam Therapeutics	$21.38 -1.0%	4/23/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$57.00	Low	View details for Wedbush rating of Beam Therapeutics (NASDAQ:BEAM) on 4/23/2024
LOGI Logitech International	$79.26 +0.7%	4/23/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$92.00	Low	View details for Wedbush rating of Logitech International (NASDAQ:LOGI) on 4/23/2024
PEP PepsiCo	$175.58 -0.6%	4/23/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$195.00	Low	View details for Wedbush rating of PepsiCo (NASDAQ:PEP) on 4/23/2024
TSCO Tractor Supply	$273.90 +3.3%	4/23/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$235.00 -> $235.00	Low	View details for Wedbush rating of Tractor Supply (NASDAQ:TSCO) on 4/23/2024
CATY Cathay General Bancorp	$35.04 +0.2%	4/23/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$44.00	Low	View details for Wedbush rating of Cathay General Bancorp (NASDAQ:CATY) on 4/23/2024
W Wayfair	$52.01 +2.1%	4/22/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$70.00	Low	View details for Wedbush rating of Wayfair (NYSE:W) on 4/22/2024
REXR Rexford Industrial Realty	$43.20 +0.5%	4/22/2024	Initiated by	Wedbush	Analyst R. Anderson	Neutral	$45.00	Low	View details for Wedbush rating of Rexford Industrial Realty (NYSE:REXR) on 4/22/2024
SKX Skechers U.S.A.	$65.41 +11.2%	4/19/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$68.00	Low	View details for Wedbush rating of Skechers U.S.A. (NYSE:SKX) on 4/19/2024
GPC Genuine Parts	$159.93 -0.7%	4/19/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$140.00 -> $170.00	Low	View details for Wedbush rating of Genuine Parts (NYSE:GPC) on 4/19/2024
BYON Beyond	$21.49 +1.3%	4/19/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$43.00	Low	View details for Wedbush rating of Beyond (NYSE:BYON) on 4/19/2024
NFLX Netflix	$561.23 -0.6%	4/19/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$725.00	Low	View details for Wedbush rating of Netflix (NASDAQ:NFLX) on 4/19/2024
ROKU Roku	$56.35 -10.3%	4/19/2024	Target Lowered by	Wedbush	-	Outperform -> Outperform	$120.00 -> $80.00	Low	View details for Wedbush rating of Roku (NASDAQ:ROKU) on 4/19/2024
TSLA Tesla	$168.29 -1.1%	4/19/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$300.00	Low	View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 4/19/2024
WAL Western Alliance Bancorporation	$58.68 +0.1%	4/19/2024	Target Lowered by	Wedbush	-	Outperform -> Outperform	$75.00 -> $70.00	Low	View details for Wedbush rating of Western Alliance Bancorporation (NYSE:WAL) on 4/19/2024
TCBI Texas Capital Bancshares	$57.81 -1.4%	4/19/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$64.00 -> $61.00	Low	View details for Wedbush rating of Texas Capital Bancshares (NASDAQ:TCBI) on 4/19/2024
BKNG Booking	$3,521.08 +0.5%	4/18/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$3,850.00	Low	View details for Wedbush rating of Booking (NASDAQ:BKNG) on 4/18/2024
ABNB Airbnb	$164.23 +0.7%	4/18/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$160.00	Low	View details for Wedbush rating of Airbnb (NASDAQ:ABNB) on 4/18/2024
EXPE Expedia Group	$135.70 -0.4%	4/18/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$130.00	Low	View details for Wedbush rating of Expedia Group (NASDAQ:EXPE) on 4/18/2024
YOU Clear Secure	$17.54 +2.0%	4/18/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$23.00 -> $21.00	Low	View details for Wedbush rating of Clear Secure (NYSE:YOU) on 4/18/2024
TRIP Tripadvisor	$27.45 +4.6%	4/18/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$30.00	Low	View details for Wedbush rating of Tripadvisor (NASDAQ:TRIP) on 4/18/2024
ARGX argenx	$372.80 +1.1%	4/18/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$521.00	Low	View details for Wedbush rating of argenx (NASDAQ:ARGX) on 4/18/2024
DHI D.R. Horton	$145.33 +0.8%	4/18/2024	Reiterated by	Wedbush	Analyst J. Mccanless	Underperform -> Underperform	$130.00	Low	View details for Wedbush rating of D.R. Horton (NYSE:DHI) on 4/18/2024
IMAX IMAX	$17.15 -1.8%	4/18/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$22.00	Low	View details for Wedbush rating of IMAX (NYSE:IMAX) on 4/18/2024
AMC AMC Entertainment	$3.41 +4.0%	4/18/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$6.00 -> $4.00	Low	View details for Wedbush rating of AMC Entertainment (NYSE:AMC) on 4/18/2024
WTFC Wintrust Financial	$99.01 -0.2%	4/18/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$116.00	Low	View details for Wedbush rating of Wintrust Financial (NASDAQ:WTFC) on 4/18/2024
CFG Citizens Financial Group	$35.15 +0.4%	4/18/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$38.00 -> $35.00	Low	View details for Wedbush rating of Citizens Financial Group (NYSE:CFG) on 4/18/2024
CNK Cinemark	$17.65 +1.0%	4/18/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$20.00 -> $23.00	Low	View details for Wedbush rating of Cinemark (NYSE:CNK) on 4/18/2024
SNBR Sleep Number	$14.18 -0.4%	4/17/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$13.50	Low	View details for Wedbush rating of Sleep Number (NASDAQ:SNBR) on 4/17/2024
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>>
TTWO Take-Two Interactive Software	$144.47 +0.7%	4/17/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$190.00	Low	View details for Wedbush rating of Take-Two Interactive Software (NASDAQ:TTWO) on 4/17/2024
INTC Intel	$31.88 -9.2%	4/17/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$40.00	Low	View details for Wedbush rating of Intel (NASDAQ:INTC) on 4/17/2024
AMD Advanced Micro Devices	$157.40 +2.4%	4/17/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$200.00	Low	View details for Wedbush rating of Advanced Micro Devices (NASDAQ:AMD) on 4/17/2024
APLS Apellis Pharmaceuticals	$49.86 +4.0%	4/17/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$67.00 -> $57.00	N/A	View details for Wedbush rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 4/17/2024
ARDX Ardelyx	$6.42 +1.7%	4/17/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$13.00 -> $14.00	N/A	View details for Wedbush rating of Ardelyx (NASDAQ:ARDX) on 4/17/2024
BIIB Biogen	$208.90 +3.2%	4/17/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$245.00 -> $213.00	N/A	View details for Wedbush rating of Biogen (NASDAQ:BIIB) on 4/17/2024
NBIX Neurocrine Biosciences	$135.99 -1.3%	4/17/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$147.00	N/A	View details for Wedbush rating of Neurocrine Biosciences (NASDAQ:NBIX) on 4/17/2024
SAGE Sage Therapeutics	$13.69 +0.8%	4/17/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$24.00	N/A	View details for Wedbush rating of Sage Therapeutics (NASDAQ:SAGE) on 4/17/2024
TVTX Travere Therapeutics	$5.26 -2.4%	4/17/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$13.00	N/A	View details for Wedbush rating of Travere Therapeutics (NASDAQ:TVTX) on 4/17/2024
TCRX TScan Therapeutics	$7.32 +0.4%	4/17/2024	Reiterated by	Wedbush	-	Outperform	$10.00	Low	View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 4/17/2024
KMX CarMax	$69.59 +0.5%	4/16/2024	Reiterated by	Wedbush	Analyst S. Basham	Outperform -> Outperform	$90.00	Low	View details for Wedbush rating of CarMax (NYSE:KMX) on 4/16/2024
EWTX Edgewise Therapeutics	$16.17 +1.4%	4/16/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$26.00	Low	View details for Wedbush rating of Edgewise Therapeutics (NASDAQ:EWTX) on 4/16/2024
RARE Ultragenyx Pharmaceutical	$44.24 +0.9%	4/16/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$48.00	Low	View details for Wedbush rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 4/16/2024
CAVA CAVA Group	$69.16 +10.5%	4/16/2024	Target Raised by	Wedbush	Analyst N. Setyan	Outperform -> Outperform	$65.00 -> $74.00	Low	View details for Wedbush rating of CAVA Group (NYSE:CAVA) on 4/16/2024
PVH PVH	$111.03 +0.2%	4/15/2024	Upgraded by	Wedbush	Analyst T. Nikic	Neutral -> Outperform	$113.00 -> $128.00	Low	View details for Wedbush rating of PVH (NYSE:PVH) on 4/15/2024
RLYB Rallybio	$1.70 +3.0%	4/11/2024	Target Lowered by	Wedbush	-	Outperform -> Outperform	$13.00 -> $11.00	Low	View details for Wedbush rating of Rallybio (NASDAQ:RLYB) on 4/11/2024
CGNT Cognyte Software	$6.90 +0.6%	4/11/2024	Target Raised by	Wedbush	-	Neutral -> Neutral	$5.00 -> $8.00	Low	View details for Wedbush rating of Cognyte Software (NASDAQ:CGNT) on 4/11/2024
APP AppLovin	$73.82 +6.7%	4/11/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$67.00 -> $87.00	Low	View details for Wedbush rating of AppLovin (NASDAQ:APP) on 4/11/2024
ALPN Alpine Immune Sciences	$64.56 -0.1%	4/11/2024	Downgraded by	Wedbush	Analyst R. Driscoll	Outperform -> Neutral		Low	View details for Wedbush rating of Alpine Immune Sciences (NASDAQ:ALPN) on 4/11/2024
WD Walker & Dunlop	$93.21 +1.2%	4/11/2024	Downgraded by	Wedbush	-	Outperform -> Neutral	$130.00 -> $95.00	Low	View details for Wedbush rating of Walker & Dunlop (NYSE:WD) on 4/11/2024
AIRC Apartment Income REIT	$38.41 -0.1%	4/11/2024	Reiterated by	Wedbush	-	Outperform -> Neutral	$35.00 -> $39.00	Low	View details for Wedbush rating of Apartment Income REIT (NYSE:AIRC) on 4/11/2024
RWT Redwood Trust	$5.72 +0.9%	4/11/2024	Downgraded by	Wedbush	Analyst J. Mccanless	Outperform -> Neutral	$8.00 -> $6.50	Low	View details for Wedbush rating of Redwood Trust (NYSE:RWT) on 4/11/2024
ABR Arbor Realty Trust	$12.82 +2.2%	4/11/2024	Reiterated by	Wedbush	Analyst J. Mccanless	Outperform -> Neutral	$17.00 -> $13.00	Low	View details for Wedbush rating of Arbor Realty Trust (NYSE:ABR) on 4/11/2024
WD Walker & Dunlop	$93.21 +1.2%	4/10/2024	Reiterated by	Wedbush	Analyst J. Mccanless	Outperform -> Neutral	$130.00 -> $95.00	Low	View details for Wedbush rating of Walker & Dunlop (NYSE:WD) on 4/10/2024
AMZN Amazon.com	$179.62 +3.4%	4/10/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$220.00	Low	View details for Wedbush rating of Amazon.com (NASDAQ:AMZN) on 4/10/2024
BROS Dutch Bros	$28.59 -1.0%	4/10/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$37.00	Low	View details for Wedbush rating of Dutch Bros (NYSE:BROS) on 4/10/2024
CHKP Check Point Software Technologies	$151.20 -1.1%	4/10/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$185.00	Low	View details for Wedbush rating of Check Point Software Technologies (NASDAQ:CHKP) on 4/10/2024
DECK Deckers Outdoor	$833.46 +3.3%	4/10/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$1,000.00	Low	View details for Wedbush rating of Deckers Outdoor (NYSE:DECK) on 4/10/2024
DPZ Domino's Pizza	$499.07 +0.9%	4/10/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$520.00	Low	View details for Wedbush rating of Domino’s Pizza (NYSE:DPZ) on 4/10/2024
EPAM EPAM Systems	$237.75 +0.3%	4/10/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$340.00	Low	View details for Wedbush rating of EPAM Systems (NYSE:EPAM) on 4/10/2024
FHN First Horizon	$14.81 +0.1%	4/10/2024	Reiterated by	Wedbush	Analyst D. Chiaverini	Outperform -> Outperform	$17.00	Low	View details for Wedbush rating of First Horizon (NYSE:FHN) on 4/10/2024
GERN Geron	$3.79 +6.5%	4/10/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$6.00	Low	View details for Wedbush rating of Geron (NASDAQ:GERN) on 4/10/2024
IMAX IMAX	$17.15 -1.8%	4/10/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$22.00	Low	View details for Wedbush rating of IMAX (NYSE:IMAX) on 4/10/2024
MGPI MGP Ingredients	$80.54 +1.7%	4/10/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$120.00	Low	View details for Wedbush rating of MGP Ingredients (NASDAQ:MGPI) on 4/10/2024
MSFT Microsoft	$406.32 +1.8%	4/10/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$500.00	Low	View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 4/10/2024
MTB M&T Bank	$146.38 -0.4%	4/10/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$170.00	Low	View details for Wedbush rating of M&T Bank (NYSE:MTB) on 4/10/2024
PEGA Pegasystems	$61.80 +4.6%	4/10/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$90.00	Low	View details for Wedbush rating of Pegasystems (NASDAQ:PEGA) on 4/10/2024
SIMO Silicon Motion Technology	$73.35 +0.6%	4/10/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$85.00	Low	View details for Wedbush rating of Silicon Motion Technology (NASDAQ:SIMO) on 4/10/2024
STZ Constellation Brands	$260.04 -0.6%	4/10/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$300.00	Low	View details for Wedbush rating of Constellation Brands (NYSE:STZ) on 4/10/2024
TENB Tenable	$45.99 +1.3%	4/10/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$65.00	Low	View details for Wedbush rating of Tenable (NASDAQ:TENB) on 4/10/2024
TPX Tempur Sealy International	$49.92 +0.1%	4/10/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$66.00	Low	View details for Wedbush rating of Tempur Sealy International (NYSE:TPX) on 4/10/2024
GOOGL Alphabet	$171.95 +10.2%	4/10/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$175.00	Low	View details for Wedbush rating of Alphabet (NASDAQ:GOOGL) on 4/10/2024
CAKE Cheesecake Factory	$35.36 +1.4%	4/10/2024	Reiterated by	Wedbush	Analyst N. Setyan	Outperform -> Outperform	$40.00	Low	View details for Wedbush rating of Cheesecake Factory (NASDAQ:CAKE) on 4/10/2024
FHTX Foghorn Therapeutics	$5.49 +5.0%	4/10/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$13.00	Low	View details for Wedbush rating of Foghorn Therapeutics (NASDAQ:FHTX) on 4/10/2024
AAPL Apple	$169.30 -0.3%	4/9/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$250.00	Low	View details for Wedbush rating of Apple (NASDAQ:AAPL) on 4/9/2024
AVTE Aerovate Therapeutics	$21.75 +0.8%	4/4/2024	Reiterated by	Wedbush	Analyst L. Chico	Outperform		Low	View details for Wedbush rating of Aerovate Therapeutics (NASDAQ:AVTE) on 4/4/2024
INZY Inozyme Pharma	$4.44 +2.5%	4/8/2024	Reiterated by	Wedbush	-	Outperform	$15.00	Low	View details for Wedbush rating of Inozyme Pharma (NASDAQ:INZY) on 4/8/2024
GEO The GEO Group	$14.87 +0.5%	4/8/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$15.00 -> $22.00	Low	View details for Wedbush rating of The GEO Group (NYSE:GEO) on 4/8/2024
CXW CoreCivic	$15.06 +0.6%	4/8/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$18.00 -> $19.00	Low	View details for Wedbush rating of CoreCivic (NYSE:CXW) on 4/8/2024
BDTX Black Diamond Therapeutics	$5.89 +15.3%	4/8/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$10.00 -> $16.00	Low	View details for Wedbush rating of Black Diamond Therapeutics (NASDAQ:BDTX) on 4/8/2024
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>>
AXTI AXT	$2.97 +2.4%	4/8/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$6.00	Low	View details for Wedbush rating of AXT (NASDAQ:AXTI) on 4/8/2024
OVID Ovid Therapeutics	$3.10 +3.7%	4/5/2024	Initiated by	Wedbush	-	Outperform	$8.00	Low	View details for Wedbush rating of Ovid Therapeutics (NASDAQ:OVID) on 4/5/2024
GOSS Gossamer Bio	$0.67 -0.3%	4/5/2024	Initiated by	Wedbush	-	Outperform	$4.00	Low	View details for Wedbush rating of Gossamer Bio (NASDAQ:GOSS) on 4/5/2024
TXRH Texas Roadhouse	$157.46 +0.4%	4/5/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$160.00 -> $170.00	Low	View details for Wedbush rating of Texas Roadhouse (NASDAQ:TXRH) on 4/5/2024
STRO Sutro Biopharma	$3.42	4/3/2024	Reiterated by	Wedbush	-	Outperform	$8.00	Low	View details for Wedbush rating of Sutro Biopharma (NASDAQ:STRO) on 4/3/2024
HBI Hanesbrands	$4.48 +0.2%	4/3/2024	Target Raised by	Wedbush	-	Neutral -> Neutral	$4.50 -> $5.00	Low	View details for Wedbush rating of Hanesbrands (NYSE:HBI) on 4/3/2024
PAYX Paychex	$119.97 -1.6%	4/3/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$115.00	Low	View details for Wedbush rating of Paychex (NASDAQ:PAYX) on 4/3/2024
INTC Intel	$31.88 -9.2%	4/3/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$40.00	Low	View details for Wedbush rating of Intel (NASDAQ:INTC) on 4/3/2024
BROS Dutch Bros	$28.59 -1.0%	4/3/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$37.00	Low	View details for Wedbush rating of Dutch Bros (NYSE:BROS) on 4/3/2024
KNSA Kiniksa Pharmaceuticals	$17.88 +1.5%	4/2/2024	Reiterated by	Wedbush	-	Outperform	$28.00 -> $30.00	Low	View details for Wedbush rating of Kiniksa Pharmaceuticals (NASDAQ:KNSA) on 4/2/2024
KMX CarMax	$69.59 +0.5%	4/2/2024	Target Raised by	Wedbush	Analyst S. Basham	Outperform -> Outperform	$90.00 -> $100.00	Low	View details for Wedbush rating of CarMax (NYSE:KMX) on 4/2/2024
PRME Prime Medicine	$4.43 +3.0%	4/2/2024	Initiated by	Wedbush	-	Outperform	$12.00	Low	View details for Wedbush rating of Prime Medicine (NYSE:PRME) on 4/2/2024
DHI D.R. Horton	$145.33 +0.8%	4/2/2024	Downgraded by	Wedbush	Analyst J. Mccanless	Neutral -> Underperform	$130.00	Low	View details for Wedbush rating of D.R. Horton (NYSE:DHI) on 4/2/2024
MTH Meritage Homes	$169.48 +2.7%	4/2/2024	Downgraded by	Wedbush	Analyst J. Mccanless	Neutral -> Underperform	$155.00 -> $148.00	Low	View details for Wedbush rating of Meritage Homes (NYSE:MTH) on 4/2/2024
CCS Century Communities	$78.82 +0.6%	4/2/2024	Reiterated by	Wedbush	Analyst J. Mccanless	Neutral -> Underperform	$92.00 -> $82.00	Low	View details for Wedbush rating of Century Communities (NYSE:CCS) on 4/2/2024
LEN Lennar	$154.29 +1.0%	4/2/2024	Reiterated by	Wedbush	Analyst J. Mccanless	Neutral -> Underperform	$144.00	Low	View details for Wedbush rating of Lennar (NYSE:LEN) on 4/2/2024
LGIH LGI Homes	$95.85 +1.0%	4/2/2024	Reiterated by	Wedbush	Analyst J. Mccanless	Neutral -> Underperform	$88.00 -> $74.00	Low	View details for Wedbush rating of LGI Homes (NASDAQ:LGIH) on 4/2/2024
IRON Disc Medicine	$27.55 +3.9%	4/1/2024	Reiterated by	Wedbush	-	Outperform	$84.00 -> $43.00	Low	View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 4/1/2024
IMNM Immunome	$13.73 -3.7%	4/1/2024	Target Raised by	Wedbush	Analyst D. Nierengarten	Outperform -> Outperform	$27.00 -> $33.00	Low	View details for Wedbush rating of Immunome (NASDAQ:IMNM) on 4/1/2024
HD Home Depot	$335.09 +0.9%	4/1/2024	Target Raised by	Wedbush	Analyst S. Basham	Outperform -> Outperform	$380.00 -> $410.00	Low	View details for Wedbush rating of Home Depot (NYSE:HD) on 4/1/2024
ASO Academy Sports and Outdoors	$60.72 +2.8%	4/1/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$80.00	Low	View details for Wedbush rating of Academy Sports and Outdoors (NASDAQ:ASO) on 4/1/2024
TSLA Tesla	$168.29 -1.1%	3/28/2024	Target Lowered by	Wedbush	-	Outperform -> Outperform	$315.00 -> $300.00	Low	View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 3/28/2024
RH RH	$248.91 +2.3%	3/28/2024	Target Raised by	Wedbush	-	Neutral -> Neutral	$275.00 -> $320.00	Low	View details for Wedbush rating of RH (NYSE:RH) on 3/28/2024
TRNO Terreno Realty	$54.13 -0.6%	3/28/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$67.00	Low	View details for Wedbush rating of Terreno Realty (NYSE:TRNO) on 3/28/2024
GPRO GoPro	$1.73 +1.2%	3/27/2024	Reiterated by	Wedbush	Analyst A. Reese	Neutral	$2.00	Low	View details for Wedbush rating of GoPro (NASDAQ:GPRO) on 3/27/2024
NVCR NovoCure	$12.64 +3.4%	3/27/2024	Reiterated by	Wedbush	-	Neutral	$21.00	Low	View details for Wedbush rating of NovoCure (NASDAQ:NVCR) on 3/27/2024
STKS ONE Group Hospitality	$5.21 +1.8%	3/27/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$5.00	Low	View details for Wedbush rating of ONE Group Hospitality (NASDAQ:STKS) on 3/27/2024
NFLX Netflix	$561.23 -0.6%	3/27/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$615.00 -> $725.00	Low	View details for Wedbush rating of Netflix (NASDAQ:NFLX) on 3/27/2024
APRE Aprea Therapeutics	$5.20 -2.8%	3/27/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$9.00 -> $11.00	Low	View details for Wedbush rating of Aprea Therapeutics (NASDAQ:APRE) on 3/27/2024
NKE NIKE	$94.12 +0.2%	3/27/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$115.00	Low	View details for Wedbush rating of NIKE (NYSE:NKE) on 3/27/2024
GME GameStop	$11.90 +6.2%	3/27/2024	Target Lowered by	Wedbush	-	Underperform -> Underperform	$6.00 -> $5.60	Low	View details for Wedbush rating of GameStop (NYSE:GME) on 3/27/2024
STOK Stoke Therapeutics	$12.41 +6.2%	3/26/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$13.00 -> $17.00	Low	View details for Wedbush rating of Stoke Therapeutics (NASDAQ:STOK) on 3/26/2024
STRO Sutro Biopharma	$3.42	3/26/2024	Target Lowered by	Wedbush	-	Outperform -> Outperform	$12.00 -> $8.00	Low	View details for Wedbush rating of Sutro Biopharma (NASDAQ:STRO) on 3/26/2024
ATXS Astria Therapeutics	$9.00 -1.9%	3/26/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$17.00	Low	View details for Wedbush rating of Astria Therapeutics (NASDAQ:ATXS) on 3/26/2024
MSFT Microsoft	$406.32 +1.8%	3/26/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$475.00 -> $500.00	Low	View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 3/26/2024
WLDN Willdan Group	$28.30 +3.2%	3/25/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$30.00 -> $35.00	Low	View details for Wedbush rating of Willdan Group (NASDAQ:WLDN) on 3/25/2024
UMH UMH Properties	$15.66 +0.2%	3/25/2024	Reiterated by	Wedbush	Analyst R. Anderson	Neutral	$17.00	Low	View details for Wedbush rating of UMH Properties (NYSE:UMH) on 3/25/2024
CMPX Compass Therapeutics	$1.45 -2.0%	3/22/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$8.00	Low	View details for Wedbush rating of Compass Therapeutics (NASDAQ:CMPX) on 3/22/2024
DNTH Dianthus Therapeutics	$21.50 +2.4%	3/22/2024	Target Raised by	Wedbush	Analyst L. Chico	Outperform -> Outperform	$24.00 -> $33.00	Low	View details for Wedbush rating of Dianthus Therapeutics (NASDAQ:DNTH) on 3/22/2024
DRI Darden Restaurants	$156.10 -0.3%	3/22/2024	Target Lowered by	Wedbush	-	Outperform -> Outperform	$187.00 -> $181.00	Low	View details for Wedbush rating of Darden Restaurants (NYSE:DRI) on 3/22/2024
MGPI MGP Ingredients	$80.54 +1.7%	3/22/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$120.00	Low	View details for Wedbush rating of MGP Ingredients (NASDAQ:MGPI) on 3/22/2024
ASO Academy Sports and Outdoors	$60.72 +2.8%	3/22/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$80.00	Low	View details for Wedbush rating of Academy Sports and Outdoors (NASDAQ:ASO) on 3/22/2024
RH RH	$248.91 +2.3%	3/22/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$275.00	Low	View details for Wedbush rating of RH (NYSE:RH) on 3/22/2024
GOOGL Alphabet	$171.95 +10.2%	3/22/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$160.00 -> $175.00	Low	View details for Wedbush rating of Alphabet (NASDAQ:GOOGL) on 3/22/2024
LULU Lululemon Athletica	$364.70 +1.3%	3/22/2024	Target Lowered by	Wedbush	-	Outperform -> Outperform	$548.00 -> $492.00	Low	View details for Wedbush rating of Lululemon Athletica (NASDAQ:LULU) on 3/22/2024
CMG Chipotle Mexican Grill	$3,186.97 +2.4%	3/22/2024	Target Raised by	Wedbush	Analyst N. Setyan	Neutral -> Neutral	$2,400.00 -> $2,850.00	Low	View details for Wedbush rating of Chipotle Mexican Grill (NYSE:CMG) on 3/22/2024
IRON Disc Medicine	$27.55 +3.9%	3/21/2024	Reiterated by	Wedbush	-	Outperform	$79.00 -> $84.00	Low	View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 3/21/2024
WSM Williams-Sonoma	$282.16 +0.2%	3/21/2024	Reiterated by	Wedbush	Analyst S. Basham	Outperform -> Outperform	$330.00	Low	View details for Wedbush rating of Williams-Sonoma (NYSE:WSM) on 3/21/2024
GEO The GEO Group	$14.87 +0.5%	3/21/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$15.00	Low	View details for Wedbush rating of The GEO Group (NYSE:GEO) on 3/21/2024
CXW CoreCivic	$15.06 +0.6%	3/21/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$18.00	Low	View details for Wedbush rating of CoreCivic (NYSE:CXW) on 3/21/2024
The Next Step of Their Control Is Here … (Ad) Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you. 4 simple steps to protect your privacy and money before it’s too late.
MU Micron Technology	$114.84 +2.9%	3/21/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$103.00 -> $130.00	Low	View details for Wedbush rating of Micron Technology (NASDAQ:MU) on 3/21/2024
AAPL Apple	$169.30 -0.3%	3/21/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$250.00	Low	View details for Wedbush rating of Apple (NASDAQ:AAPL) on 3/21/2024
ALIT Alight	$9.11	3/21/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$13.00 -> $14.00	Low	View details for Wedbush rating of Alight (NYSE:ALIT) on 3/21/2024
TYRA Tyra Biosciences	$15.67 +3.7%	3/21/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$28.00	Low	View details for Wedbush rating of Tyra Biosciences (NASDAQ:TYRA) on 3/21/2024
KBH KB Home	$65.60 +2.1%	3/21/2024	Target Raised by	Wedbush	Analyst J. Mccanless	Neutral -> Neutral	$60.00 -> $64.00	Low	View details for Wedbush rating of KB Home (NYSE:KBH) on 3/21/2024
VOR Vor Biopharma	$1.69 -0.6%	3/21/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$11.00	Low	View details for Wedbush rating of Vor Biopharma (NYSE:VOR) on 3/21/2024
CHWY Chewy	$15.84 +3.0%	3/21/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$25.00	Low	View details for Wedbush rating of Chewy (NYSE:CHWY) on 3/21/2024
VERA Vera Therapeutics	$39.65 +2.5%	3/21/2024	Target Raised by	Wedbush	-	Neutral -> Neutral	$21.00 -> $34.00	Low	View details for Wedbush rating of Vera Therapeutics (NASDAQ:VERA) on 3/21/2024
ACET Adicet Bio	$1.68 -7.2%	3/20/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$5.00	Low	View details for Wedbush rating of Adicet Bio (NASDAQ:ACET) on 3/20/2024
SDHC Smith Douglas Homes	$27.25 +5.5%	3/20/2024	Reiterated by	Wedbush	Analyst J. Mccanless	Neutral -> Neutral	$23.00	Low	View details for Wedbush rating of Smith Douglas Homes (NYSE:SDHC) on 3/20/2024
DSGN Design Therapeutics	$3.78 +0.5%	3/20/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$5.00	Low	View details for Wedbush rating of Design Therapeutics (NASDAQ:DSGN) on 3/20/2024
FUSN Fusion Pharmaceuticals	$21.42 +0.1%	3/19/2024	Downgraded by	Wedbush	Analyst D. Nierengarten	Outperform -> Neutral	$24.00	N/A	View details for Wedbush rating of Fusion Pharmaceuticals (NASDAQ:FUSN) on 3/19/2024
BLUE bluebird bio	$0.92 +1.1%	3/19/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$1.72 -> $1.68	Low	View details for Wedbush rating of bluebird bio (NASDAQ:BLUE) on 3/19/2024
ALPN Alpine Immune Sciences	$64.56 -0.1%	3/19/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$47.00	Low	View details for Wedbush rating of Alpine Immune Sciences (NASDAQ:ALPN) on 3/19/2024
LEGH Legacy Housing	$20.30 +1.1%	3/19/2024	Target Lowered by	Wedbush	-	Outperform -> Outperform	$31.00 -> $25.00	Low	View details for Wedbush rating of Legacy Housing (NASDAQ:LEGH) on 3/19/2024
NCMI National CineMedia	$4.47 -2.6%	3/19/2024	Target Raised by	Wedbush	-	Neutral -> Neutral	$4.50 -> $5.50	Low	View details for Wedbush rating of National CineMedia (NASDAQ:NCMI) on 3/19/2024
NVDA NVIDIA	$877.35 +6.2%	3/19/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$1,000.00	Low	View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 3/19/2024
NKE NIKE	$94.12 +0.2%	3/19/2024	Target Lowered by	Wedbush	-	Outperform -> Outperform	$131.00 -> $115.00	Low	View details for Wedbush rating of NIKE (NYSE:NKE) on 3/19/2024
LEN Lennar	$154.29 +1.0%	3/18/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$130.00 -> $144.00	Low	View details for Wedbush rating of Lennar (NYSE:LEN) on 3/18/2024
TNGX Tango Therapeutics	$7.44 +1.5%	3/18/2024	Reiterated by	Wedbush	-	Outperform	$18.00	Low	View details for Wedbush rating of Tango Therapeutics (NASDAQ:TNGX) on 3/18/2024
LOGI Logitech International	$79.26 +0.7%	3/18/2024	Reiterated by	Wedbush	-	Neutral	$92.00	Low	View details for Wedbush rating of Logitech International (NASDAQ:LOGI) on 3/18/2024
TSLA Tesla	$168.29 -1.1%	3/13/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$315.00	Low	View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 3/13/2024
MLTX MoonLake Immunotherapeutics	$42.49 +0.6%	3/13/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$92.00	Low	View details for Wedbush rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 3/13/2024
LBPH Longboard Pharmaceuticals	$19.72 +2.4%	3/13/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$32.00	Low	View details for Wedbush rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 3/13/2024
PRPL Purple Innovation	$1.52 +1.0%	3/13/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$1.25 -> $2.25	Low	View details for Wedbush rating of Purple Innovation (NASDAQ:PRPL) on 3/13/2024
BIRD Allbirds	$0.61 -0.5%	3/13/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$1.00 -> $0.90	Low	View details for Wedbush rating of Allbirds (NASDAQ:BIRD) on 3/13/2024
TPX Tempur Sealy International	$49.92 +0.1%	3/13/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$60.00 -> $66.00	Low	View details for Wedbush rating of Tempur Sealy International (NYSE:TPX) on 3/13/2024
INFY Infosys	$16.94 -0.4%	3/13/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$22.00	Low	View details for Wedbush rating of Infosys (NYSE:INFY) on 3/13/2024
DRI Darden Restaurants	$156.10 -0.3%	3/15/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$177.00 -> $187.00	Low	View details for Wedbush rating of Darden Restaurants (NYSE:DRI) on 3/15/2024
PGY Pagaya Technologies	$10.40 +7.3%	3/15/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$18.00 -> $11.50	Low	View details for Wedbush rating of Pagaya Technologies (NASDAQ:PGY) on 3/15/2024
GERN Geron	$3.79 +6.5%	3/15/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$6.00	Low	View details for Wedbush rating of Geron (NASDAQ:GERN) on 3/15/2024
DECK Deckers Outdoor	$833.46 +3.3%	3/15/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$895.00 -> $1,000.00	Low	View details for Wedbush rating of Deckers Outdoor (NYSE:DECK) on 3/15/2024
RMBL RumbleOn	$4.88 -1.6%	3/15/2024	Target Lowered by	Wedbush	-	Outperform -> Outperform	$7.50 -> $7.00	Low	View details for Wedbush rating of RumbleOn (NASDAQ:RMBL) on 3/15/2024
DKS DICK'S Sporting Goods	$207.12 +1.4%	3/15/2024	Target Raised by	Wedbush	-	Neutral -> Neutral	$160.00 -> $210.00	Low	View details for Wedbush rating of DICK’S Sporting Goods (NYSE:DKS) on 3/15/2024
SKLZ Skillz	$6.10 -2.1%	3/15/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$15.00	Low	View details for Wedbush rating of Skillz (NYSE:SKLZ) on 3/15/2024
GETY Getty Images	$3.92 +0.5%	3/15/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$7.70	Low	View details for Wedbush rating of Getty Images (NYSE:GETY) on 3/15/2024
STKS ONE Group Hospitality	$5.21 +1.8%	3/15/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$6.00 -> $5.00	Low	View details for Wedbush rating of ONE Group Hospitality (NASDAQ:STKS) on 3/15/2024
NHI National Health Investors	$62.89 +0.4%	3/18/2024	Target Raised by	Wedbush	Analyst R. Anderson	Outperform -> Outperform	$64.00 -> $66.00	Low	View details for Wedbush rating of National Health Investors (NYSE:NHI) on 3/18/2024
TSVT 2seventy bio	$4.26 -0.7%	3/18/2024	Reiterated by	Wedbush	Analyst D. Nierengarten	Neutral -> Neutral	$5.00	Low	View details for Wedbush rating of 2seventy bio (NASDAQ:TSVT) on 3/18/2024
FENC Fennec Pharmaceuticals	$9.21 +0.5%	3/18/2024	Reiterated by	Wedbush	-	Outperform	$16.00	Low	View details for Wedbush rating of Fennec Pharmaceuticals (NASDAQ:FENC) on 3/18/2024
HEAR Turtle Beach	$14.14 +0.6%	3/14/2024	Reiterated by	Wedbush	-	Outperform	$14.00 -> $19.00	N/A	View details for Wedbush rating of Turtle Beach (NASDAQ:HEAR) on 3/14/2024
S SentinelOne	$21.56 +1.7%	3/14/2024	Target Raised by	Wedbush	-	Overweight -> Overweight	$28.00 -> $32.00	Low	View details for Wedbush rating of SentinelOne (NYSE:S) on 3/14/2024
JACK Jack in the Box	$58.79 +0.6%	3/14/2024	Upgraded by	Wedbush	Analyst N. Setyan	Neutral -> Outperform	$79.00 -> $88.00	Low	View details for Wedbush rating of Jack in the Box (NASDAQ:JACK) on 3/14/2024
CLSD Clearside Biomedical	$1.34 +6.3%	3/13/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$5.00 -> $4.00	Low	View details for Wedbush rating of Clearside Biomedical (NASDAQ:CLSD) on 3/13/2024
BDTX Black Diamond Therapeutics	$5.89 +15.3%	3/13/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$10.00	Low	View details for Wedbush rating of Black Diamond Therapeutics (NASDAQ:BDTX) on 3/13/2024
GEO The GEO Group	$14.87 +0.5%	3/13/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$15.00	Low	View details for Wedbush rating of The GEO Group (NYSE:GEO) on 3/13/2024
NCMI National CineMedia	$4.47 -2.6%	3/12/2024	Reiterated by	Wedbush	-	Neutral	$4.50	Low	View details for Wedbush rating of National CineMedia (NASDAQ:NCMI) on 3/12/2024
INZY Inozyme Pharma	$4.44 +2.5%	3/12/2024	Reiterated by	Wedbush	-	Outperform	$15.00	Low	View details for Wedbush rating of Inozyme Pharma (NASDAQ:INZY) on 3/12/2024
IKNA Ikena Oncology	$1.30 -0.8%	3/12/2024	Reiterated by	Wedbush	-	Outperform	$8.00	Low	View details for Wedbush rating of Ikena Oncology (NASDAQ:IKNA) on 3/12/2024
MU Micron Technology	$114.84 +2.9%	3/12/2024	Reiterated by	Wedbush	-	Outperform	$95.00 -> $103.00	Low	View details for Wedbush rating of Micron Technology (NASDAQ:MU) on 3/12/2024
ANAB AnaptysBio	$21.00 +11.3%	3/12/2024	Upgraded by	Wedbush	Analyst D. Nierengarten	Neutral -> Outperform	$20.00 -> $34.00	Low	View details for Wedbush rating of AnaptysBio (NASDAQ:ANAB) on 3/12/2024
JANX Janux Therapeutics	$47.39 +0.6%	3/11/2024	Reiterated by	Wedbush	-	Outperform	$53.00	Low	View details for Wedbush rating of Janux Therapeutics (NASDAQ:JANX) on 3/11/2024
SPRY ARS Pharmaceuticals	$8.35 +3.2%	3/11/2024	Reiterated by	Wedbush	-	Outperform	$19.00	Low	View details for Wedbush rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 3/11/2024
PLTR Palantir Technologies	$22.52 +3.7%	3/8/2024	Reiterated by	Wedbush	-	Outperform	$30.00 -> $35.00	Low	View details for Wedbush rating of Palantir Technologies (NYSE:PLTR) on 3/8/2024
PEPG PepGen	$11.93 +2.0%	3/7/2024	Target Lowered by	Wedbush	-	Outperform -> Outperform	$21.00 -> $20.00	Low	View details for Wedbush rating of PepGen (NASDAQ:PEPG) on 3/7/2024
ELEV Elevation Oncology	$3.62 -0.8%	3/7/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$5.00 -> $8.00	Low	View details for Wedbush rating of Elevation Oncology (NASDAQ:ELEV) on 3/7/2024
GBIO Generation Bio	$2.90 -3.7%	3/7/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$5.00	Low	View details for Wedbush rating of Generation Bio (NASDAQ:GBIO) on 3/7/2024
WSM Williams-Sonoma	$282.16 +0.2%	3/7/2024	Target Raised by	Wedbush	Analyst S. Basham	Outperform -> Outperform	$230.00 -> $280.00	Low	View details for Wedbush rating of Williams-Sonoma (NYSE:WSM) on 3/7/2024
NYCB New York Community Bancorp	$2.97 -3.3%	3/7/2024	Target Lowered by	Wedbush	Analyst D. Chiaverini	Underperform -> Underperform	$3.50 -> $3.00	N/A	View details for Wedbush rating of New York Community Bancorp (NYSE:NYCB) on 3/7/2024
SOFI SoFi Technologies	$7.87 +3.7%	3/6/2024	Reiterated by	Wedbush	Analyst D. Chiaverini	Underperform -> Underperform	$3.00	Low	View details for Wedbush rating of SoFi Technologies (NASDAQ:SOFI) on 3/6/2024

MarketBeat Community Rating for Wedbush

Community Ranking:		2.7 out of 5 ( 2.7 of 5 stars)
Outperform Votes:		24,227 (Vote Outperform)
Underperform Votes:		20,954 (Vote Underperform)
Total Votes:		45,181

MarketBeat's community ratings are surveys of what our community members think about Wedbush and other research firms. Vote "Outperform" if you believe Wedbush's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Wedbush's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Wedbush Analyst Recommendations & Stock Picks

MarketBeat Community Rating for Wedbush

Stock Ratings Reports and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info